HeartMate-3 Ventricular Assist Devices Versus the Total Artificial Heart for Biventricular Support: A Single-Center Series

The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient character...

Full description

Saved in:
Bibliographic Details
Published inASAIO journal (1992) Vol. 69; no. 6; p. 544
Main Authors Satish, Mohan, Anyanwu, Anelechi, Moss, Noah, Lala, Anuradha, Itagaki, Shinobu, Roldan, Julie, Mancini, Donna
Format Journal Article
LanguageEnglish
Published United States 01.06.2023
Online AccessGet more information

Cover

Loading…
Abstract The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient characteristics and outcomes between two HeartMate-3 (HM-3) VADs in comparison with TAH support. All patients who received durable biventricular mechanical support from November 2018 to May 2022 at The Mount Sinai Hospital (New York) were considered. Baseline clinical, echocardiographic, hemodynamic, and outcome data were extracted. Primary outcomes were postoperative survival and successful bridge-to-transplant (BTT). A total of 16 patients received durable biventricular mechanical support during the study period, of which 6 (38%) patients received two HM-3 VAD pumps as BiVAD support and 10 (62%) patients received a TAH. Overall, TAH patients had a lower median lactate ( p < 0.05) at baseline compared to those on HM-3 BiVAD support yet had higher operative morbidity, lower 6-month survival ( p < 0.05), and a higher rate of renal failure (80 vs . 17%; p = 0.03). However, survival declined to the same rate at 1 year (50%) and was largely because of extracardiac adverse events related to underlying comorbidities (particularly, renal failure and diabetes, p < 0.05). Successful BTT was achieved in 3 out of 6 HM-3 BiVAD patients and in 5 out of 10 TAH patients. In our single center experience, similar outcomes were observed among patients BTT with HM-3 BiVAD compared to those BTT on TAH support despite lower Interagency Registry for Mechanically Assisted Circulatory Support level.
AbstractList The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient characteristics and outcomes between two HeartMate-3 (HM-3) VADs in comparison with TAH support. All patients who received durable biventricular mechanical support from November 2018 to May 2022 at The Mount Sinai Hospital (New York) were considered. Baseline clinical, echocardiographic, hemodynamic, and outcome data were extracted. Primary outcomes were postoperative survival and successful bridge-to-transplant (BTT). A total of 16 patients received durable biventricular mechanical support during the study period, of which 6 (38%) patients received two HM-3 VAD pumps as BiVAD support and 10 (62%) patients received a TAH. Overall, TAH patients had a lower median lactate ( p < 0.05) at baseline compared to those on HM-3 BiVAD support yet had higher operative morbidity, lower 6-month survival ( p < 0.05), and a higher rate of renal failure (80 vs . 17%; p = 0.03). However, survival declined to the same rate at 1 year (50%) and was largely because of extracardiac adverse events related to underlying comorbidities (particularly, renal failure and diabetes, p < 0.05). Successful BTT was achieved in 3 out of 6 HM-3 BiVAD patients and in 5 out of 10 TAH patients. In our single center experience, similar outcomes were observed among patients BTT with HM-3 BiVAD compared to those BTT on TAH support despite lower Interagency Registry for Mechanically Assisted Circulatory Support level.
Author Mancini, Donna
Satish, Mohan
Roldan, Julie
Moss, Noah
Itagaki, Shinobu
Anyanwu, Anelechi
Lala, Anuradha
Author_xml – sequence: 1
  givenname: Mohan
  surname: Satish
  fullname: Satish, Mohan
  organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai
– sequence: 2
  givenname: Anelechi
  surname: Anyanwu
  fullname: Anyanwu, Anelechi
  organization: Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai
– sequence: 3
  givenname: Noah
  surname: Moss
  fullname: Moss, Noah
  organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai
– sequence: 4
  givenname: Anuradha
  surname: Lala
  fullname: Lala, Anuradha
  organization: Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai
– sequence: 5
  givenname: Shinobu
  surname: Itagaki
  fullname: Itagaki, Shinobu
  organization: Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai
– sequence: 6
  givenname: Julie
  surname: Roldan
  fullname: Roldan, Julie
  organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai
– sequence: 7
  givenname: Donna
  orcidid: 0000-0002-6050-1785
  surname: Mancini
  fullname: Mancini, Donna
  organization: Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36867839$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtOwzAQRS0Eog_4A4T8Aym2J3FidqE8itSKRQNiV7nOBIzSJLKdSvD1RDykzuZe3SOdxUzIcdM2SMgFZzPOVHq1yosZOziuGDsiY55AFqkYXkdk4v3HsCcA_JSMQGYyzUCNydcCtQsrHTAC-oJNcNb0tXY09976QG9xbw36ATnfexrekRZt0DXNXbCVNXaoPwpatY7e2P2BYt13XevCNc3p2jZvNUbzgeIA0Fn0Z-Sk0rXH87-ckuf7u2K-iJZPD4_zfBkZYGmIQDI0UCmWbTNIykxzpXWiMTVQgkhTWaaJVpKBYCiFjmXMhRTGJJXUUsZGTMnlr7frtzssN52zO-0-N_9PEN8n22AW
CitedBy_id crossref_primary_10_1016_j_bbe_2023_12_005
crossref_primary_10_1093_icvts_ivad139
ContentType Journal Article
Copyright Copyright © ASAIO 2023.
Copyright_xml – notice: Copyright © ASAIO 2023.
DBID NPM
DOI 10.1097/MAT.0000000000001900
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1538-943X
ExternalDocumentID 36867839
Genre Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
0R~
23N
4Q1
4Q2
4Q3
5GY
5RE
5VS
AAAAV
AAHPQ
AAIQE
AAJCS
AAMTA
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADGGA
ADHPY
AEBDS
AENEX
AFDTB
AFEXH
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJIOK
AJNWD
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BQLVK
C45
CS3
DIWNM
E.X
EBS
EEVPB
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
O9-
OAG
OAH
ODA
ODMTH
OHYEH
OK1
OL1
OLG
OLV
OLZ
OPUJH
OVD
OVDNE
OWW
OWY
OXXIT
P2P
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
WH7
WOQ
WOW
X3V
X3W
YFH
ZFV
ZGI
ID FETCH-LOGICAL-c307t-360ec3f908b835d8a19aa5ae7c3d32776d75a960320e62a4641262cc5f6a664c2
IngestDate Thu May 23 23:32:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright © ASAIO 2023.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c307t-360ec3f908b835d8a19aa5ae7c3d32776d75a960320e62a4641262cc5f6a664c2
ORCID 0000-0002-6050-1785
PMID 36867839
ParticipantIDs pubmed_primary_36867839
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ASAIO journal (1992)
PublicationTitleAlternate ASAIO J
PublicationYear 2023
SSID ssj0015331
Score 2.3875544
Snippet The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a...
SourceID pubmed
SourceType Index Database
StartPage 544
Title HeartMate-3 Ventricular Assist Devices Versus the Total Artificial Heart for Biventricular Support: A Single-Center Series
URI https://www.ncbi.nlm.nih.gov/pubmed/36867839
Volume 69
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6IU17QdxhXOQH3iaP1HbshLcMgQoi5aEd2tvkOI5aaUunkmra_s7-KMeXXDYGAvqQVnFlVf6-Hh-fnPMdhN7yopJCGEa0MJRwLiOiaKqJKjW8RUVaSVucnE_F5Ih_OY6PR6PrQdbSpikO9NWddSX_gyrcA1xtlew_INtNCjfgM-ALV0AYrn-F8QRo2uTgLRK2_92GaZc-qxTWHNCzCUHWDOzbmNjmh3Mx5ytb_JitXYbQ0gsLrxuXa3ho7V43he32aZvMu8L1Gexvp4bYSLBZW_PSZh628rWz7PO3ToTCSj-lKR3EGGa2hMLFb_LVoqdjVl-q-mLj8yptP57FssM_NHOfrvp49Vd16oPA9WatyoUaBiwo6xOrDszAyHLXB7izwr5hS2Db0KTGXh_yF1PvJYTzbO4lKMML_Jto-HVYpvMzBz8TCWzMXjnpz6O3BLjboS20JRNrRKc2IBQeVIG3PG4rMlP57q6fs4t22ilunV2cDzN_gO6HwwfOPJMeopGpH6GdPKRXPEZXA0LhAaGwJxQOhMKeUBgIhR2hcE8o7KbAQCh8g1A4EOo9zvANOmFPpyfo6NPH-YcJCc05iIZtoSFMREazKo2SApz4MlHjVKlYGalZyaiUopSxguMxo5ERVHHBx1RQreNKKCG4pk_Rdr2qzXOEE6FSZqKoqsaGw4E9TeAMo2QVG5HwMjYv0DO_aifnXoHlpF3Pvd-OvES7PfdeoXsV_OXNa_Afm-KNQ_AnoI1tjQ
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HeartMate-3+Ventricular+Assist+Devices+Versus+the+Total+Artificial+Heart+for+Biventricular+Support%3A+A+Single-Center+Series&rft.jtitle=ASAIO+journal+%281992%29&rft.au=Satish%2C+Mohan&rft.au=Anyanwu%2C+Anelechi&rft.au=Moss%2C+Noah&rft.au=Lala%2C+Anuradha&rft.date=2023-06-01&rft.eissn=1538-943X&rft.volume=69&rft.issue=6&rft.spage=544&rft_id=info:doi/10.1097%2FMAT.0000000000001900&rft_id=info%3Apmid%2F36867839&rft_id=info%3Apmid%2F36867839&rft.externalDocID=36867839